ARCHIVES

NIH director; Targets Increases Favor Established Researchers

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

Henderson Committee Final Recommendation Made On P01s

February 10, 1984

In brief: Shalala Meets HIV-Infected Children; Einstein’s Kornblith Moves To PCI; Yang Leaves Center

March 12, 1993

NCI Trials Listed

June 25, 2010

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report

February 27, 1976